Cecere Annagrazia, Martini Marika, Bueno Marinas Maria, Rigato Ilaria, Parodi Alessandro, Pilichou Kalliopi, Bauce Barbara
Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padova, 35128 Padova, Italy.
J Clin Med. 2025 Aug 8;14(16):5611. doi: 10.3390/jcm14165611.
Arrhythmogenic cardiomyopathy (ACM) is an inherited heart disorder characterized by structural and functional myocardial alterations, often accompanied by ventricular arrhythmias (VAs), which may ultimately result in sudden cardiac death (SCD). While mutations in genes coding for desmosomal components are commonly identified in affected individuals, genetic variants involving non-desmosomal proteins have recently been recognized as contributors to the disease's etiology. In 2008, a mutation in the transmembrane protein 43 () was identified as being responsible for a fully penetrant, sex-related, and severe form of ACM. This review aimed to systematically synthesize the current evidence on the natural history, electrocardiographic, and imaging findings as well as the clinical outcomes of cardiomyopathy. A systematic search was performed in the PubMed, Scopus, and Web of Science databases, following the PRISMA guidelines, using the terms "TMEM43" AND "cardiomyopathy". After an initial screening of 144 retrieved articles, 80 were considered relevant. Upon a full-text review and eligibility assessment, 12 studies involving 903 individuals harboring TMEM43 variants were selected for inclusion. Male patients more frequently carried the pathogenic variant ( = 505, 55.9%) and exhibited an earlier arrhythmic onset of the disease (33.2 years old versus 46.2 years old in female patients), supporting the need for earlier implantable cardioverter-defibrillator implantation (30.4 versus 42.2 years old). Palpitations, chest pain, and syncope were the most common presenting symptoms. Baseline electrocardiograms commonly demonstrated poor R wave progression, QRS prolongation, and premature ventricular contractions (PVCs). Arrhythmic events, including malignant VAs and SCD, were early manifestations of the disease, especially in male patients. Frequent PVCs and left ventricular dilation were considered early markers of the disease and were predictive of arrhythmic events. Conversely, heart failure was reported as a late clinical outcome, requiring heart transplantation in a minority of cases (1.5%). cardiomyopathy is a fully penetrant autosomal dominant form of ACM, characterized by a well-defined clinical phenotype that is more severe and presents earlier in male patients.
致心律失常性心肌病(ACM)是一种遗传性心脏疾病,其特征为心肌结构和功能改变,常伴有室性心律失常(VAs),最终可能导致心源性猝死(SCD)。虽然在受影响个体中常见编码桥粒成分的基因突变,但涉及非桥粒蛋白的基因变异最近被认为是该疾病病因的促成因素。2008年,跨膜蛋白43()的一种突变被确定为导致一种完全显性、与性别相关的严重形式的ACM的原因。本综述旨在系统总结关于TMEM43心肌病自然史、心电图和影像学表现以及临床结局的当前证据。按照PRISMA指南,在PubMed、Scopus和Web of Science数据库中进行系统检索,使用检索词“TMEM43”和“心肌病”。在初步筛选144篇检索到的文章后,80篇被认为相关。经过全文审查和纳入标准评估,选择了12项涉及903名携带TMEM43变异的个体的研究纳入。男性患者更频繁携带致病变异(n = 505,55.9%),且疾病的心律失常发作更早(男性患者为33.2岁,女性患者为46.2岁),这支持了更早植入植入式心律转复除颤器的必要性(分别为30.4岁和42.2岁)。心悸、胸痛和晕厥是最常见的首发症状。基线心电图通常显示R波进展不良、QRS波增宽和室性早搏(PVCs)。心律失常事件,包括恶性室性心律失常和心源性猝死,是该疾病的早期表现,尤其是在男性患者中。频发室性早搏和左心室扩张被认为是该疾病的早期标志物,并可预测心律失常事件。相反,心力衰竭被报道为晚期临床结局,少数病例(1.5%)需要心脏移植。TMEM43心肌病是一种完全显性的常染色体显性形式的ACM,其特征为明确的临床表型,在男性患者中更严重且发病更早。